Global CAR T-Cell Therapy Agents Market Research Report 2024(Status and Outlook)
Report Overview:
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
The Global CAR T-Cell Therapy Agents Market Size was estimated at USD 389.83 million in 2023 and is projected to reach USD 585.03 million by 2029, exhibiting a CAGR of 7.00% during the forecast period.
This report provides a deep insight into the global CAR T-Cell Therapy Agents market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global CAR T-Cell Therapy Agents Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the CAR T-Cell Therapy Agents market in any manner.
Global CAR T-Cell Therapy Agents Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Cellectis
Allogene Therapeutics
Celyad
Market Segmentation (by Type)
CD19-targeted
BCMA-targeted
Market Segmentation (by Application)
Lymphoma
Multiple Myeloma
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the CAR T-Cell Therapy Agents Market
Overview of the regional outlook of the CAR T-Cell Therapy Agents Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the CAR T-Cell Therapy Agents Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of CAR T-Cell Therapy Agents
- 1.2 Key Market Segments
- 1.2.1 CAR T-Cell Therapy Agents Segment by Type
- 1.2.2 CAR T-Cell Therapy Agents Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 CAR T-Cell Therapy Agents Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global CAR T-Cell Therapy Agents Market Size (M USD) Estimates and Forecasts (2019-2030)
- 2.1.2 Global CAR T-Cell Therapy Agents Sales Estimates and Forecasts (2019-2030)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 CAR T-Cell Therapy Agents Market Competitive Landscape
- 3.1 Global CAR T-Cell Therapy Agents Sales by Manufacturers (2019-2024)
- 3.2 Global CAR T-Cell Therapy Agents Revenue Market Share by Manufacturers (2019-2024)
- 3.3 CAR T-Cell Therapy Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4 Global CAR T-Cell Therapy Agents Average Price by Manufacturers (2019-2024)
- 3.5 Manufacturers CAR T-Cell Therapy Agents Sales Sites, Area Served, Product Type
- 3.6 CAR T-Cell Therapy Agents Market Competitive Situation and Trends
- 3.6.1 CAR T-Cell Therapy Agents Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest CAR T-Cell Therapy Agents Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 CAR T-Cell Therapy Agents Industry Chain Analysis
- 4.1 CAR T-Cell Therapy Agents Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of CAR T-Cell Therapy Agents Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 CAR T-Cell Therapy Agents Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global CAR T-Cell Therapy Agents Sales Market Share by Type (2019-2024)
- 6.3 Global CAR T-Cell Therapy Agents Market Size Market Share by Type (2019-2024)
- 6.4 Global CAR T-Cell Therapy Agents Price by Type (2019-2024)
- 7 CAR T-Cell Therapy Agents Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global CAR T-Cell Therapy Agents Market Sales by Application (2019-2024)
- 7.3 Global CAR T-Cell Therapy Agents Market Size (M USD) by Application (2019-2024)
- 7.4 Global CAR T-Cell Therapy Agents Sales Growth Rate by Application (2019-2024)
- 8 CAR T-Cell Therapy Agents Market Segmentation by Region
- 8.1 Global CAR T-Cell Therapy Agents Sales by Region
- 8.1.1 Global CAR T-Cell Therapy Agents Sales by Region
- 8.1.2 Global CAR T-Cell Therapy Agents Sales Market Share by Region
- 8.2 North America
- 8.2.1 North America CAR T-Cell Therapy Agents Sales by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe CAR T-Cell Therapy Agents Sales by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific CAR T-Cell Therapy Agents Sales by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America CAR T-Cell Therapy Agents Sales by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa CAR T-Cell Therapy Agents Sales by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Novartis
- 9.1.1 Novartis CAR T-Cell Therapy Agents Basic Information
- 9.1.2 Novartis CAR T-Cell Therapy Agents Product Overview
- 9.1.3 Novartis CAR T-Cell Therapy Agents Product Market Performance
- 9.1.4 Novartis Business Overview
- 9.1.5 Novartis CAR T-Cell Therapy Agents SWOT Analysis
- 9.1.6 Novartis Recent Developments
- 9.2 Gilead Sciences
- 9.2.1 Gilead Sciences CAR T-Cell Therapy Agents Basic Information
- 9.2.2 Gilead Sciences CAR T-Cell Therapy Agents Product Overview
- 9.2.3 Gilead Sciences CAR T-Cell Therapy Agents Product Market Performance
- 9.2.4 Gilead Sciences Business Overview
- 9.2.5 Gilead Sciences CAR T-Cell Therapy Agents SWOT Analysis
- 9.2.6 Gilead Sciences Recent Developments
- 9.3 Bristol-Myers Squibb
- 9.3.1 Bristol-Myers Squibb CAR T-Cell Therapy Agents Basic Information
- 9.3.2 Bristol-Myers Squibb CAR T-Cell Therapy Agents Product Overview
- 9.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Agents Product Market Performance
- 9.3.4 Bristol-Myers Squibb CAR T-Cell Therapy Agents SWOT Analysis
- 9.3.5 Bristol-Myers Squibb Business Overview
- 9.3.6 Bristol-Myers Squibb Recent Developments
- 9.4 J and J
- 9.4.1 J and J CAR T-Cell Therapy Agents Basic Information
- 9.4.2 J and J CAR T-Cell Therapy Agents Product Overview
- 9.4.3 J and J CAR T-Cell Therapy Agents Product Market Performance
- 9.4.4 J and J Business Overview
- 9.4.5 J and J Recent Developments
- 9.5 JW Therapeutics
- 9.5.1 JW Therapeutics CAR T-Cell Therapy Agents Basic Information
- 9.5.2 JW Therapeutics CAR T-Cell Therapy Agents Product Overview
- 9.5.3 JW Therapeutics CAR T-Cell Therapy Agents Product Market Performance
- 9.5.4 JW Therapeutics Business Overview
- 9.5.5 JW Therapeutics Recent Developments
- 9.6 FOSUNKite
- 9.6.1 FOSUNKite CAR T-Cell Therapy Agents Basic Information
- 9.6.2 FOSUNKite CAR T-Cell Therapy Agents Product Overview
- 9.6.3 FOSUNKite CAR T-Cell Therapy Agents Product Market Performance
- 9.6.4 FOSUNKite Business Overview
- 9.6.5 FOSUNKite Recent Developments
- 9.7 CARsgen Therapeutics (Pipeline)
- 9.7.1 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Basic Information
- 9.7.2 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Product Overview
- 9.7.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Product Market Performance
- 9.7.4 CARsgen Therapeutics (Pipeline) Business Overview
- 9.7.5 CARsgen Therapeutics (Pipeline) Recent Developments
- 9.8 CARsgen Therapeutics
- 9.8.1 CARsgen Therapeutics CAR T-Cell Therapy Agents Basic Information
- 9.8.2 CARsgen Therapeutics CAR T-Cell Therapy Agents Product Overview
- 9.8.3 CARsgen Therapeutics CAR T-Cell Therapy Agents Product Market Performance
- 9.8.4 CARsgen Therapeutics Business Overview
- 9.8.5 CARsgen Therapeutics Recent Developments
- 9.9 Autolus Therapeutics
- 9.9.1 Autolus Therapeutics CAR T-Cell Therapy Agents Basic Information
- 9.9.2 Autolus Therapeutics CAR T-Cell Therapy Agents Product Overview
- 9.9.3 Autolus Therapeutics CAR T-Cell Therapy Agents Product Market Performance
- 9.9.4 Autolus Therapeutics Business Overview
- 9.9.5 Autolus Therapeutics Recent Developments
- 9.10 Sorrento Therapeutics
- 9.10.1 Sorrento Therapeutics CAR T-Cell Therapy Agents Basic Information
- 9.10.2 Sorrento Therapeutics CAR T-Cell Therapy Agents Product Overview
- 9.10.3 Sorrento Therapeutics CAR T-Cell Therapy Agents Product Market Performance
- 9.10.4 Sorrento Therapeutics Business Overview
- 9.10.5 Sorrento Therapeutics Recent Developments
- 9.11 Mustang Bio
- 9.11.1 Mustang Bio CAR T-Cell Therapy Agents Basic Information
- 9.11.2 Mustang Bio CAR T-Cell Therapy Agents Product Overview
- 9.11.3 Mustang Bio CAR T-Cell Therapy Agents Product Market Performance
- 9.11.4 Mustang Bio Business Overview
- 9.11.5 Mustang Bio Recent Developments
- 9.12 Bluebird Bio
- 9.12.1 Bluebird Bio CAR T-Cell Therapy Agents Basic Information
- 9.12.2 Bluebird Bio CAR T-Cell Therapy Agents Product Overview
- 9.12.3 Bluebird Bio CAR T-Cell Therapy Agents Product Market Performance
- 9.12.4 Bluebird Bio Business Overview
- 9.12.5 Bluebird Bio Recent Developments
- 9.13 Cellectis
- 9.13.1 Cellectis CAR T-Cell Therapy Agents Basic Information
- 9.13.2 Cellectis CAR T-Cell Therapy Agents Product Overview
- 9.13.3 Cellectis CAR T-Cell Therapy Agents Product Market Performance
- 9.13.4 Cellectis Business Overview
- 9.13.5 Cellectis Recent Developments
- 9.14 Allogene Therapeutics
- 9.14.1 Allogene Therapeutics CAR T-Cell Therapy Agents Basic Information
- 9.14.2 Allogene Therapeutics CAR T-Cell Therapy Agents Product Overview
- 9.14.3 Allogene Therapeutics CAR T-Cell Therapy Agents Product Market Performance
- 9.14.4 Allogene Therapeutics Business Overview
- 9.14.5 Allogene Therapeutics Recent Developments
- 9.15 Celyad
- 9.15.1 Celyad CAR T-Cell Therapy Agents Basic Information
- 9.15.2 Celyad CAR T-Cell Therapy Agents Product Overview
- 9.15.3 Celyad CAR T-Cell Therapy Agents Product Market Performance
- 9.15.4 Celyad Business Overview
- 9.15.5 Celyad Recent Developments
- 10 CAR T-Cell Therapy Agents Market Forecast by Region
- 10.1 Global CAR T-Cell Therapy Agents Market Size Forecast
- 10.2 Global CAR T-Cell Therapy Agents Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe CAR T-Cell Therapy Agents Market Size Forecast by Country
- 10.2.3 Asia Pacific CAR T-Cell Therapy Agents Market Size Forecast by Region
- 10.2.4 South America CAR T-Cell Therapy Agents Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of CAR T-Cell Therapy Agents by Country
- 11 Forecast Market by Type and by Application (2025-2030)
- 11.1 Global CAR T-Cell Therapy Agents Market Forecast by Type (2025-2030)
- 11.1.1 Global Forecasted Sales of CAR T-Cell Therapy Agents by Type (2025-2030)
- 11.1.2 Global CAR T-Cell Therapy Agents Market Size Forecast by Type (2025-2030)
- 11.1.3 Global Forecasted Price of CAR T-Cell Therapy Agents by Type (2025-2030)
- 11.2 Global CAR T-Cell Therapy Agents Market Forecast by Application (2025-2030)
- 11.2.1 Global CAR T-Cell Therapy Agents Sales (Kilotons) Forecast by Application
- 11.2.2 Global CAR T-Cell Therapy Agents Market Size (M USD) Forecast by Application (2025-2030)
- 12 Conclusion and Key Findings
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook